Literature DB >> 895636

Landry-Guillain-Barré-Strohl syndrome. A study of 302 cases.

S K Samantray, S C Johnson, K V Mathai, B M Pulimood.   

Abstract

Three hundred and two cases of Landry-Guillain-Barré-Strohl syndrome (LGBSS) are studied and relevant literature is reviewed. The existing diagnostic criteria appear not in keeping with the histopathological and immunological findings of this condition, hence some modifications have been suggested. The role of steroids in the treatment of this disorder is critically examined, and no benefit is found to be gained from their use.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 895636     DOI: 10.5694/j.1326-5377.1977.tb99056.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes.

Authors:  T Kanda; H Hayashi; H Tanabe; T Tsubaki; M Oda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

2.  Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.

Authors:  R P Kleyweg; F G van der Meché
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

Review 3.  [Guillain Barré syndrome and diabetic acido-ketotic decompensation during pregnancy: a case report and review of the literature].

Authors:  Lilia Affes; Mouna Elleuch; Fatma Mnif; Faten Hadj Kacem; Dhouha Ben Salah; Mouna Mnif; Nadia Charfi; Nabila Rekik; Mohamed Abid
Journal:  Pan Afr Med J       Date:  2017-02-21

4.  Fulminant guillain-barré syndrome mimicking cerebral death following acute viral hepatitis a.

Authors:  Bong-Hui Kang; Kwang-Kuk Kim
Journal:  J Clin Neurol       Date:  2007-06-20       Impact factor: 3.077

5.  Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

Authors:  J Terryberry; M Sutjita; Y Shoenfeld; B Gilburd; D Tanne; M Lorber; I Alosachie; N Barka; H C Lin; P Youinou
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.